Clinical Trials

12,370 Followers

Blockchain
DATAx: How blockchain may revolutionize clinical trials | Articles | Big Data
theinnovationenterprise.com - channels.theinnovationenterprise.com
Despite the hype, blockchain still has very few mainstream use cases. It is becoming easier for critics to balk at the technology as no more than …
Markets Insideradded this to Markets Insider
Food Allergies
DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit
Business Insider - PRESS RELEASE GlobeNewswire
Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated
Markets Insideradded this to Markets Insider
Garmin
Garmin® Health and ActiGraph™ collaborate on wearable solutions for clinical trials
Business Insider - PRESS RELEASE Businesswire
Garmin International, Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced a collaboration with ActiGraph to explore creation of innovative health and activity monitoring solutions that would utilize
Networking
Lawsuit alleges NIH, FDA let clinical trial sponsors off the hook - STAT
statnews.com - By Sharon Begley
• Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and …
Psychology
Studies Support Use of Team-Based Care for Early Psychosis
nih.gov - www.nimh.nih.gov
Researchers continue to build on findings from NIMH’s Recovery After an Initial Schizophrenia Episode (RAISE) program, which investigated the …
Seeking Alpha
Summit Therapeutics Q3 revenues down 73%
Seeking Alpha - Mamta Mayani
Summit Therapeutics (SMMT) Q3 results (£): Revenues: 0.7M (-73.1%). Net Loss: (8.1M); Loss Per Share: (0.10); Quick Assets: 13M (-35.3%); CF Ops: …
Investing.com Canadaadded this to STOCK MARKETS
BRIEF-Acerus Announces Results Of Clinical Trial With A Formulation Of Cannabis Oil
investing.com
Dec 11 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO : * ACERUS ANNOUNCES RESULTS OF PHASE 1 CLINICAL TRIAL WITH A PROPRIETARY INTRANASAL …
Seeking Alpha
Biomarkers
Aravive Biologics initiates phase 1b portion of phase 1b/2 clinical trial of AVB-S6-500
Seeking Alpha - Mamta Mayani
Aravive (NASDAQ:ARAV) has initiated Phase 1b portion of a Phase 1b/Phase 2 trial combining AVB-S6-500 with standard-of-care therapies in patients …
The San Diego Union-Tribuneadded this to News
San Diego
Drug effective against cancer that killed Steve Jobs arrives in San Diego
sandiegouniontribune.com - Bradley J. Fikes
A drug effective against the rare and deadly cancer that killed Apple co-founder Steve Jobs has arrived in San Diego. Called Lutathera, it selectively …
Markets Insideradded this to Markets Insider
Biopharmaceutical
Save The Date For Achillion Pharma
Business Insider - RTTNews
(RTTNews) - Achillion Pharmaceuticals Inc. (ACHN), which is slated to report clinical data next week, has gained 7% so far this month. Achillion Pharma is a clinical-stage biopharmaceutical company developing
Medical News Today
Alzheimer's Disease
Future of Alzheimer's therapy: What is the best approach?
Medical News Today - By Maria Cohut
Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer's disease. Currently, there is no way to halt its …
Associated Press
TSX Venture Exchange
Pascal Biosciences Announces Year-End Investor Update Webcast
Associated Press - Pascal Biosciences Inc.
Advancement of Cannabinoid Cancer Programs and Corporate Review to be Presented Scheduled for Dec. 17, 2018 at 1:30 p.m. Pacific VANCOUVER, British Columbia and SEATTLE, Dec. 10, 2018 (GLOBE NEWSWIRE)
Cleveland Clinic
Have You or a Loved One Been Diagnosed with Lung Cancer?
clevelandclinic.org - pages.clevelandclinic.org
Cleveland Clinic Florida's multi-disciplinary approach to cancer care allows us to focus the energies of our entire team on providing the best …
Associated Press
Philanthropy
Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Associated Press - Fibrocell Science Inc.
EXTON, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue today
Scientific Americanadded this to Scientific American
Science
We Need More Minorities in Clinical Trials
scientificamerican.com - Marjorie A. Speers
Concern over the lack of significant minority participation by patients in clinical trials has waxed and waned over the past 30 years. Now, there is …
Seeking Alpha
Mergers & Acquisitions
RedHill closes $20M equity offering
Seeking Alpha - Douglas W. House
RedHill Biopharma (RDHL +0.6%) has closed its public offering of ~2.9M ADSs at $7/ADS yielding ~$20M. Net proceeds will help fund preparations for the …
Immune System
Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018
yahoo.com - GlobeNewswire
NEW HAVEN, Conn., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (ACHN), a clinical-stage biopharmaceutical company focused on …
FDA
2018 in Review, 2019 in Focus
michaeljfox.org - www.michaeljfox.org
At The Michael J. Fox Foundation (MJFF), we're reaching new milestones every year and looking ahead to advancing the most promising research toward …
Medicine
Effect of Oral Alfacalcidol on Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis
jamanetwork.com
Create a free personal account to download free article PDFs, sign up for alerts, customize your interests, and more
pogluadded this to INTERESTING STUFF
Medicine
About NIDA
drugabuse.gov - National Institute on Drug Abuse
• Strategically supporting and conducting basic and clinical research on drug use (including nicotine), its consequences, and the underlying …
Postpartum
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression
yahoo.com - GlobeNewswire
Ganaxolone was safe and well-tolerated Ganaxolone IV demonstrated fast-acting, robust and durable efficacy Interim data with ganaxolone oral supports …
The Conversation Australiaadded this to Science & Technology
Hearing Loss
How researchers assess whether medications work
theconversation.com - Yasmine Probst and Lauren Houston
This article is in the series This is research, where we ask academics to share and discuss open access articles that reveal important aspects of …
Mayo Clinic
Living With Cancer: Does pomegranate juice slow progression of prostate cancer?
mayoclinic.org - By Laurel J. Kelly
Pomegranate juice and prostate cancer Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer. While those …
Seeking Alpha
Sinusitis
Optinose enrolls first patient in clinical trial of XHANCE for chronic sinusitis
Seeking Alpha - Mamta Mayani
Optinose (NASDAQ:OPTN) enrolls first patient in a global clinical trial to evaluate the safety and efficacy of XHANCE (fluticasone propionate) nasal …
Markets Insideradded this to Markets Insider
Celiac Disease
AKAO Abuzz, PRVB On High Pulse, Mark Your Calendar For INNT
Business Insider - RTTNews
(RTTNews) - The following are some of today's top gainers in the pharma/biotech sector. 1. Innovate Biopharmaceuticals Inc. (INNT) Gained 38.39% to close Monday's (Dec.10) trading at $3.10. News: No news
Psoriasis
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with
yahoo.com - GlobeNewswire
Company to Conduct Conference Call and Webcast Today at 8:00am ET / 5:00am PT REDWOOD CITY, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Menlo …
Markets Insideradded this to Markets Insider
Freedom of Information
Global Market for Contract Research Organization (CRO) Services
Business Insider - PRESS RELEASE PR Newswire
NEW YORK, Dec. 10, 2018 /PRNewswire/ -- Report Scope The Global CRO market is identified in this report along with all major global CRO companies.The total CRO market is broken out globally and by geographic
Seeking Alpha
San Antonio
Zymeworks presents IND-enabling data of ZW49 at the San Antonio Breast Cancer Symposium
Seeking Alpha - Mamta Mayani
Zymeworks (NYSE:ZYME) presents IND-enabling data for ZW49, a biparatopic HER2-targeted antibody-drug conjugates (ADC), at the San Antonio Breast …
Stanford University
Clinical Research Coordinator | ChEM-H
stanford.edu - chemh.stanford.edu
Clinical Research Coordinator, Stanford ChEM-H Job Purpose Conduct clinical research and work independently on multiple projects involving human …
Markets Insideradded this to Markets Insider
Asia Pacific
Medidata recognized as Asia Pacific Clinical Trial IT Solutions Provider of the Year by Frost & Sullivan
Business Insider - PRESS RELEASE PR Newswire
SINGAPORE, Dec. 9, 2018 /PRNewswire/ -- Medidata was honored with the Asia Pacific Clinical Trial IT Solutions Provider of the Year Award at the annual Frost & Sullivan Asia-Pacific Best Practices Awards